Listed by the USPTO as PHAM, KHAI QUYNH TIEN
Tech Center 1600 • Art Units: 1637 1639 1672 1675 1678 1682 1683 1684
This examiner grants 0% of resolved cases
PHAM, KHAI QUYNH TIEN works in tech center 1600 and art unit 1637. The profile contains 2 resolved cases, a 0.0% allowance rate, and a median of 1212 days to allowance. The 0.0% interview lift indicates no observed interview association with allowance outcomes in the available record.
10x Genomics Inc., University of Washington, and Illumina Inc. are the leading listed companies. The listed firms are CHOATE, HALL & STEWART LLP, Barclay Damon, LLP, and Bookoff McAndrews, PLLC. The extremely limited case history does not support broad prosecution predictions, making application-specific claim analysis especially important.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18268538 | BIOCATALYTIC PLATFORM FOR CHEMICAL SYNTHESIS | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF MICHIGAN |
| 18377068 | Methods and Systems for Processing Polynucleotides | Non-Final OA | 10X GENOMICS, INC. |
| 18049880 | METHODS AND SYSTEMS FOR INCREASING CELL RECOVERY EFFICIENCY | Non-Final OA | 10x Genomics, Inc. |
| 18653004 | METHOD OF IDENTIFYING ALLOSTERIC BIOSENSOR PROTEINS WITH NEW SPECIFICITIES | Non-Final OA | Wisconsin Alumni Research Foundation |
| 18652519 | DIGITAL COUNTING OF INDIVIDUAL MOLECULES BY STOCHASTIC ATTACHMENT OF DIVERSE LABELS | Non-Final OA | Becton, Dickinson and Company |
| 18512453 | METHODS AND SYSTEMS FOR DETECTING PEPTIDE AGGREGATES | Non-Final OA | Rensselaer Polytechnic Institute |
| 18654545 | HIGH-THROUGHPUT SINGLE-CELL SEQUENCING WITH REDUCED AMPLIFICATION BIAS | Non-Final OA | University of Washington |
| 18649435 | MASSIVELY PARALLEL CONTIGUITY MAPPING | Non-Final OA | University of Washington through its Center for Commercialization |
| 17926566 | NUCLEIC ACID SAMPLE ENRICHMENT AND SCREENING METHODS | Non-Final OA | Myriad Women's Health, Inc. |
| 18571069 | APTAMER DYNAMIC RANGE COMPRESSION AND DETECTION TECHNIQUES | Non-Final OA | ILLUMINA, INC. |
| 18473564 | Compositions and Methods for Assessing DNA Damage in a Library and Normalizing Amplicon Size Bias | Non-Final OA | Illumina, Inc. |
| 18001898 | PARALLEL ANALYSIS OF INDIVIDUAL CELLS FOR RNA EXPRESSION AND DNA FROM TARGETED TAGMENTATION BY SEQUENCING | Non-Final OA | Ludwig Institute for Cancer Research Ltd |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy0.0% of resolved applications examined by Khai Quynh Tien Pham were allowed (2 resolved cases), compared with 45.4% across Art Unit 1637 over the last five years.
This examiner's interview lift is +0.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Khai Quynh Tien Pham took 1,212 days on average from filing to allowance.
Khai Quynh Tien Pham examines applications in Art Unit 1637 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
